Evidence map›Paper›PMID 41677531›Full record

ArticleNanomaterials (Basel, Switzerland)2026

Dual-Effect of S-Scheme Heterojunction and CQDs Strengthens the Charge Separation and Transfer in CQDs-g-C

Kunping Wang, Xiaojiang Su, Zhangxi Zhou, Liangqing Hu, Hao Li, Junyi Long, Ying Feng, Xiaobo Zhang, Jinghuai Zhang, Jing Feng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kunping WangKey Laboratory of Superlight Materials & Surface Technology, Ministry of Education, Harbin Engineering University, Harbin 150001, China.
Xiaojiang SuKey Laboratory of Superlight Materials & Surface Technology, Ministry of Education, Harbin Engineering University, Harbin 150001, China.
Zhangxi ZhouKey Laboratory of Superlight Materials & Surface Technology, Ministry of Education, Harbin Engineering University, Harbin 150001, China.
Liangqing HuKey Laboratory of Superlight Materials & Surface Technology, Ministry of Education, Harbin Engineering University, Harbin 150001, China.
Hao LiKey Laboratory of Superlight Materials & Surface Technology, Ministry of Education, Harbin Engineering University, Harbin 150001, China.
Junyi LongKey Laboratory of Superlight Materials & Surface Technology, Ministry of Education, Harbin Engineering University, Harbin 150001, China.
Ying FengCollege of Life Sciences, Tonghua Normal University, Tonghua 134000, China.ORCID 0000-0002-1588-9020
Xiaobo ZhangJiangsu Key Laboratory of Advanced Structural Materials and Application Technology, Nanjing Institute of Technology, Nanjing 211167, China.ORCID 0000-0003-2706-2132
Jinghuai ZhangKey Laboratory of Superlight Materials & Surface Technology, Ministry of Education, Harbin Engineering University, Harbin 150001, China.
Jing FengKey Laboratory of Superlight Materials & Surface Technology, Ministry of Education, Harbin Engineering University, Harbin 150001, China.ORCID 0000-0001-5997-828X

Funding

Ministry of Education, and opening project of JiangSu key laboratory of advanced structural materials and application technology ASMA202502
6 · The paper itself

Abstract

Photocatalytic degradation of tetracycline (TC) is considered a viable technology due to its stable molecular structure and resistance to absorption by biological organisms. As a promising photocatalyst, TiO

Indexed as

carbon quantum dotsg-C3N4photocatalysisS-scheme heterojunctiontetracyclineTiO2

Identifiers

PMID41677531
PMCPMC12899698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.